VertiFlex lands FDA panel date for Superion interspinous spacer

VertiFlex lands a date with the FDA's Orthopaedic & Rehabilitation Devices panel in December to consider the data behind its Superion interspinous spacer.

VertiFlex Inc. won a date with an FDA advisory panel to review the data behind its Superion interspinous spacer ahead of its bid for pre-market approval from the watchdog agency.

Food & Drug Administration (FDA), VertiFlex Inc.

News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Spinal

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1shVi1y